1. Single nucleotide polymorphisms (SNPs) are:
a. disease-causing mutations in the human genome
b. an example of standing genetic variation in the human population
c. errors during genome sequencing
d. none of the above

Single nucleotide polymorphisms (SNPs) represent standing genetic variation in human populations, making option b the correct answer.

Option Analysis

a. Disease-causing mutations in the human genome
This is incorrect because most SNPs are neutral variations occurring at a frequency greater than 1% in the population, not necessarily pathogenic mutations that directly cause disease. While some SNPs increase disease susceptibility, such as those linked to age-related macular degeneration, they do not universally cause illness.

b. An example of standing genetic variation in the human population
This is correct as SNPs are common single-base differences (e.g., A to G) present in more than 1% of individuals, accounting for about 90% of human genetic variation and serving as stable markers of population diversity.

c. Errors during genome sequencing
This is wrong since SNPs are true biological variations in DNA sequences, not technical artifacts from sequencing processes.

d. None of the above
Incorrect, as option b accurately describes SNPs.

Single nucleotide polymorphisms (SNPs) are fundamental to understanding standing genetic variation in the human genome. As the most common form of genetic variation, SNPs involve a single base pair change, like substituting guanine (G) for adenine (A), occurring in over 1% of the population. For CSIR NET Life Sciences aspirants, grasping SNPs distinguishes them from rare mutations and highlights their role in population genetics and disease association studies.

Role in Human Genetics

SNPs exemplify standing genetic variation, persisting across generations without selective pressure in most cases. They enable genome-wide association studies (GWAS) to link variants to traits, such as APOE gene SNPs influencing Alzheimer’s risk. Unlike sequencing errors or solely pathogenic changes, SNPs drive individuality, drug response, and evolutionary adaptation.

• Enable precise mapping of complex traits and diseases.

• Facilitate pharmacogenomics for personalized medicine.

• Serve as markers in linkage disequilibrium analysis.

Applications in Research

In molecular biology, SNPs power biodiversity analysis and trait mapping, crucial for biotechnology and evolutionary studies. While some SNPs in coding regions alter proteins and contribute to multifactorial diseases like diabetes, the majority remain benign. CSIR NET questions often test this nuance, emphasizing SNPs as polymorphic variants rather than errors.